We didn’t wait for the next advance against cancer. We created it.
Learn why our CSO, Nick Keen, is #NotWaiting.
We didn’t wait for the next advance against cancer. We created it.
Learn why our U.K. team is #NotWaiting.
View all news

News

20 February 2019
Bicycle Therapeutics Strengthens Executive Team with Key Changes

Social Media

@Bicycle_tx Feb 20
Bicycle welcomes Pete Leone, who joins the team as Chief Business Officer, and congratulates Lee Kalowski, Bicycle’… http://ByyyDHllKd

Our Programs

We are focused on developing three categories of Bicycles against our oncology targets:

Bicycle Toxin ConjugatesBicycle Targeted Innate Immune ActivatorsBicycle T-Cell Modulators

Our Technology

Learn about our revolutionary Bicycle technology

Beyond Oncology

Bicycle programs outside of cancer